Injective (INJ) is currently priced at $5.49, reflecting a slight decline of -0.10581% over the past 24 hours. The asset has experienced a daily trading range of $5.33 to $5.52, indicating low volatility, with a volume of approximately $49.96 million, which constitutes 9.07% of its market cap.

The hourly moving averages are showing positive momentum in the short term, with the 8 SMA at $5.45 (+0.81%) and the 13 SMA at $5.44 (+0.92%). However, the longer-term 144 SMA at $6.08 shows a significant drop of -9.65%, suggesting bearish sentiment in the mid to long term.

Technical indicators indicate mixed signals; the 1-hour RSI is at 64, approaching overbought territory, while the 7-day RSI is at 44, indicating potential weakness. The recent price changes are concerning, with a significant decline over the past 7 days (-18.25%), 14 days (-25.64%), and 30 days (-34.11%), reflecting sustained bearish pressure.

Injective's all-time high remains significantly elevated at $52.62, highlighting the potential for recovery but also the current disconnect from this level. The current price is approximately 89.6% below its all-time high, which may deter new investors but could present a buying opportunity for those seeking long-term value.

Based on the current technical indicators, the mixed RSI signals, and the significant drop in recent price changes, I recommend a Hold rating on INJ. While there is short-term momentum, the longer-term outlook remains bearish, and investors should monitor for signs of stabilization before making new purchases.